| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/30/2008 | CA2263425C Pharmaceutical agent containing rho kinase inhibitor |
| 09/30/2008 | CA2206962C Dry polymer bead preparation |
| 09/30/2008 | CA2082382C Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy |
| 09/30/2008 | CA1341581C Leukaemia inhibitory factor |
| 09/25/2008 | WO2008116233A2 A method for determining the content of metallic elements in fischer-tropsch waxes |
| 09/25/2008 | WO2008116178A2 Systems and methods for diagnosis and prognosis of colorectal cancer |
| 09/25/2008 | WO2008116150A2 Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease |
| 09/25/2008 | WO2008116083A1 Use of ranolazine for elevated brain-type natriuretic peptide |
| 09/25/2008 | WO2008116044A1 Semiconductor quantum dots for efeicient delivery and intracellular imaging of sirna |
| 09/25/2008 | WO2008116032A1 Compositions and methods for inhibiting tumor cell growth |
| 09/25/2008 | WO2008116017A1 Continuous analyte monitor with multi-point self-calibration |
| 09/25/2008 | WO2008115948A2 Positive selection procedure for optically directed selection of cells |
| 09/25/2008 | WO2008115750A2 Compositions and methods for the treatment of cancer |
| 09/25/2008 | WO2008115714A2 Evaluating rtk target drugs |
| 09/25/2008 | WO2008115710A2 Biomarkers for cancer |
| 09/25/2008 | WO2008115601A1 67lr antibodies and their uses in the treatment of cancer |
| 09/25/2008 | WO2008115580A2 Method for detecting nitrofuran |
| 09/25/2008 | WO2008115518A2 Biomarkers of sirtuin activity and methods of use thereof |
| 09/25/2008 | WO2008115517A2 Methods for identifying stem cells by detecting autofluorescence of cells and syncytia |
| 09/25/2008 | WO2008115420A2 Methods for detecting molecular interactions within cells using combination of inducible promoters and biosensors |
| 09/25/2008 | WO2008115300A1 C-kit phosphorylation in cancer |
| 09/25/2008 | WO2008115198A2 Anthrax carbohydrates,synthesis and uses thereof |
| 09/25/2008 | WO2008115120A1 Method for detecting binding and chemical reactions in an aqueous sample |
| 09/25/2008 | WO2008114980A1 Simultaneous diagnostic kit for trichomonas vaginalis and chlamydia trachomatis |
| 09/25/2008 | WO2008114917A1 Plasma kallikrein fragments as diagnostic biomarkers for lung cancers |
| 09/25/2008 | WO2008114733A1 Anti-claudin-4 antibody |
| 09/25/2008 | WO2008114672A1 Cancer-specific biomarker |
| 09/25/2008 | WO2008114544A1 Probe for visualizing cell cycle |
| 09/25/2008 | WO2008114501A1 Diagnostic agent and therapeutic agent for cancer |
| 09/25/2008 | WO2008114458A1 Cell sorter chip and cell sorter |
| 09/25/2008 | WO2008114060A1 Whole blood assay |
| 09/25/2008 | WO2008114042A1 Rhizome viability determination method |
| 09/25/2008 | WO2008114025A1 Particle facilitated testing |
| 09/25/2008 | WO2008114020A2 Mutant g-protein coupled receptors and methods for selecting them |
| 09/25/2008 | WO2008114003A1 Improvements in or relating to detection and/or characterisation of oligomers |
| 09/25/2008 | WO2008113995A1 Assessment method |
| 09/25/2008 | WO2008113870A1 Method for the diagnosis and/or prognosis of cancer of the bladder |
| 09/25/2008 | WO2008113758A1 Direct mass spectrometric analysis of drug candidates targeting protein complexes |
| 09/25/2008 | WO2008113363A1 Diagnostic test for renal injury |
| 09/25/2008 | WO2008113361A1 A flow through system, flow through device and a method of performing a test |
| 09/25/2008 | WO2008113185A1 Antagonists of ligands and uses thereof |
| 09/25/2008 | WO2008113174A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
| 09/25/2008 | WO2008113131A1 Method of screening |
| 09/25/2008 | WO2008113125A1 Methods for detection of aberrant cells of neuroectodermal origin |
| 09/25/2008 | WO2008113119A1 A cell-mediated immune response assay and kits therefor |
| 09/25/2008 | WO2008113109A1 Artificial substrate |
| 09/25/2008 | WO2008087687A3 Portable tester to check on the presence of chemical elements |
| 09/25/2008 | WO2008087349A3 Process and autonomous mobile robot for monitoring diffuse gaseous emissions emanating from an emissive site |
| 09/25/2008 | WO2008085518A3 Compositions and methods relating to organ-, tissue-, and cell-specific antibodies |
| 09/25/2008 | WO2008084319A3 Novel nucleic acid |
| 09/25/2008 | WO2008083179A3 Analyte devices and methods |
| 09/25/2008 | WO2008077397A3 Method and means for concentrating, removing, and detecting gram-positive bacteria |
| 09/25/2008 | WO2008075395A3 Method for the diagnosis and/or monitoring of invasive aspergillosis |
| 09/25/2008 | WO2008073817A3 Muc1 and galectin-3 |
| 09/25/2008 | WO2008070472A3 Use of plasma hsp90 related to malignancy |
| 09/25/2008 | WO2008067806A3 Diagnosis and risk stratification of cardiac insufficiency using neurophysin |
| 09/25/2008 | WO2008049930A3 A method for profiling kinase inhibitors |
| 09/25/2008 | WO2008043524A3 Autoantigens for improved diagnosis, prognosis and treatment of inflammatory neurological diseases |
| 09/25/2008 | WO2008033167A3 Nano-particle biochip substrates |
| 09/25/2008 | WO2008030616A3 Monitoring cancer stem cells |
| 09/25/2008 | WO2008029031A9 Pharmacodiagnostic test targeting oncology |
| 09/25/2008 | WO2008028692A3 Method for screening drug candidates for inflammatory diseases mediated by lps-inducible cc chemokine receptor mechanism |
| 09/25/2008 | WO2008021493A3 A process for identification of molecular mimicry and the uses thereof |
| 09/25/2008 | WO2007090125A8 Prognostic factors for anti-hyperproliferative disease gene therapy |
| 09/25/2008 | WO2007089753A3 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 09/25/2008 | WO2007058878A3 Mechanisms of osteoinduction by lim mineralization protein-1 (lmp-1) |
| 09/25/2008 | WO2007040546A3 Production of recombinant protein pap 31 for the diagnosis and prevention of bartonella bacilliformis infection |
| 09/25/2008 | WO2007014044A3 Biological detection based on differentially coupled nanomechanical systems using self-sensing cantilevers with attonewton force resolution |
| 09/25/2008 | WO2005113795A3 Hematology reference control containing an immature granulocyte component |
| 09/25/2008 | US20080235053 Communication medium for diabetes management |
| 09/25/2008 | US20080234947 Scientist domain-centric user interface and enabling "soft" translation |
| 09/25/2008 | US20080234943 Computer program for diabetes management |
| 09/25/2008 | US20080234941 Method of Designing Sirnas for Gene Silencing |
| 09/25/2008 | US20080234470 Kcnb: a novel potassium channel protein |
| 09/25/2008 | US20080234468 Isdolated nucleic acids; coding polypeptide; therapy for central nervous system disorders |
| 09/25/2008 | US20080234393 Compounds and methods for detection of carcinomas and their precursor lesions |
| 09/25/2008 | US20080234365 Non-nuclear effects of thyroid hormone |
| 09/25/2008 | US20080234311 IMMUNOASSAY FOR DETECTION AND QUANTIFICATION OF AMYLOID-beta PEPTIDES |
| 09/25/2008 | US20080234264 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
| 09/25/2008 | US20080234219 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 09/25/2008 | US20080234216 TGF-beta type receptor cDNAs encoded products and uses therefor |
| 09/25/2008 | US20080234204 Methods for evaluating and implementing prostate disease treatments |
| 09/25/2008 | US20080234185 Use of Dmbt1 for Capturing Sulphate and Phosphate Group Exposing Agents |
| 09/25/2008 | US20080234175 Reaction mixture of a complex of an negative-sense NS1 protein of influenza virus, or a douple stranded (ds)RNA binding fragment of it, and a dsRNA that binds the protein; targets for drug design; small scale and/or high-throughput screening for inhibitors of interactions between NS1A or NS1B, and dsRNA, |
| 09/25/2008 | US20080234139 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 09/25/2008 | US20080234137 Assay Method for Group Transfer Reactions |
| 09/25/2008 | US20080233660 Solid phase labeling method |
| 09/25/2008 | US20080233659 Process of screening for alpha-thalassemia carrier using immunochromatographic strip test |
| 09/25/2008 | US20080233657 Assaying a sample for the presence of a genotype associated with antidepressant medication, genotype of 5-hydroxytryptamine (serotonin) receptor 2A, glutamine receptor, ionotropic, kainate 4 and /or B-cell leukemia/lymphoma 2 |
| 09/25/2008 | US20080233656 Method For Detecting a Fuel Additive Component |
| 09/25/2008 | US20080233655 Screening For Lysosomal Storage Disease Status |
| 09/25/2008 | US20080233654 An aqueous solution of urea and a tracer composition comprising a phenol; selective catalytic reduction system to remove NOx from diesel exhaust |
| 09/25/2008 | US20080233640 Prostate cancer; CD133 antigen, alpha 2 beta 1 integrin, human epithelial antigen and CD44 antigen |
| 09/25/2008 | US20080233637 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 09/25/2008 | US20080233635 particle differentiation device; identifying and separating sperm cells according to chromosomal complement; photomultiplier tube converts light from light emission source into one differentiation signal; cattle, sheep, and/or horse in vitro fertilization and veterinary medicine |
| 09/25/2008 | US20080233605 assaying glycated protein, fructosyl peptide, or fructosyl amino acid which can be performed with reduced effect of fructosyl lysine compounds; by causing an enzyme to act specifically on fructosyl peptide or fructosyl amino acid at a pH of 4.0 to 7.0 |
| 09/25/2008 | US20080233604 Methods For Identifying Compounds Capable of Modulating the Hydrolase Activity of Clca Protein |
| 09/25/2008 | US20080233603 Fluorine NMR spectroscopy for biochemical screening |
| 09/25/2008 | US20080233602 Detecting and profiling molecular complexes |
| 09/25/2008 | US20080233601 Norbornenes are important monomers in ring-opening metathesis polymerizations; ELISAs that use the compounds and polymers as a chemiluminescent detection label |